Марказий Осиё эндокринологик журнали 4-tom 1-san (2024)

ROLE OF ORAL HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Даминова Л.Т, Садикова Д.Ш, Муминова C.У

Derekkózde oqıw PDF

Annotaciya

For patients with diabetes, one of the main therapeutic goals is to achieve target glycemic levels. In the presence of NAFLD, the attending physician is faced with some restrictions when choosing glucose-lowering therapy. The drugs, in addition to sufficient glucose-lowering activity, must be safe for the liver and not have hepatotoxicity. In addition, glucose-lowering drugs must have proven cardiovascular safety, since type 2 diabetes and NAFLD mutually aggravate not only each other’s course, but also significantly increase cardiovascular risk.

сахарный диабет 2 типа, НАЖБП, сахароснижающие препаратыType 2 diabetes, NAFLD, hypoglycemic drugsQandli diabet 2 turi, NAYJK, gipoglikemik preparatlar

Metadata derekkózi: jurnal OAI-PMH arxivi · Sindex tolıq mátindi saqlamaydı, derekkózge silteme beredi.

Dáyeksóz alıw

APA 7 
Даминова Л.Т, Садикова Д.Ш & Муминова C.У (2024). ROLE OF ORAL HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. Марказий Осиё эндокринологик журнали, 4(1).
GOST R 7.0.5 
Даминова Л.Т, Садикова Д.Ш, Муминова C.У ROLE OF ORAL HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE // Марказий Осиё эндокринологик журнали. 2024. Т. 4. № 1.
BibTeX 
@article{л.т2024,
  author  = {Даминова Л.Т and Садикова Д.Ш and Муминова C.У},
  title   = {ROLE OF ORAL HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE},
  journal = {Марказий Осиё эндокринологик журнали},
  year    = {2024},
  volume  = {4},
  number  = {1}
}
RIS 
TY  - JOUR
AU  - Даминова Л.Т
AU  - Садикова Д.Ш
AU  - Муминова C.У
TI  - ROLE OF ORAL HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
JO  - Марказий Осиё эндокринологик журнали
PY  - 2024
VL  - 4
IS  - 1
ER  -